India based Sun Pharmaceutical Industries Ltd is recalling 200 vials of cancer drug, gemcitabine, in the US due to a lack of assurance of sterility, the US Food and Drug Administration said Thursday. The voluntary recall was initiated in April, citing that use of or exposure to the recalled drug may cause temporary or medically reversible adverse health consequences.